![Christopher Dinsmore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Dinsmore
Corporate Officer/Principal at
Stablix, Inc.
Profile
Christopher Dinsmore currently works at Wisconsin Alumni Research Foundation, as Advisor and Stablix, Inc., as Scientific Advisory.
Dr. Dinsmore also formerly worked at Merck & Co., Inc., as Executive Director-Discovery Chemistry, Forma Therapeutics, Inc., as VP-Medicinal & Computational Chemistry from 2014 to 2019, Third Rock Ventures LLC, as Entrepreneur-Residence from 2019 to 2020, Kronos Bio, Inc., as Chief Scientific Officer from 2020 to 2024, and Third Harmonic Bio, Inc., as Chief Scientific Officer from 2024 to 2025.
Dr. Dinsmore received his undergraduate degree from Bowdoin College and doctorate degree from the University of Minnesota.
Christopher Dinsmore active positions
| Companies | Position | Start |
|---|---|---|
Stablix, Inc.
 Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Corporate Officer/Principal | - |
Wisconsin Alumni Research Foundation
 Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Provides research patenting and licensing services | Corporate Officer/Principal | - |
Former positions of Christopher Dinsmore
| Companies | Position | End |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Chief Tech/Sci/R&D Officer | 21/04/2025 |
| KRONOS BIO, INC. | Chief Tech/Sci/R&D Officer | 16/02/2024 |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Corporate Officer/Principal | 02/06/2020 |
Forma Therapeutics, Inc.
 Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Corporate Officer/Principal | 01/06/2019 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Training of Christopher Dinsmore
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
33
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation Miscellaneous Commercial ServicesCommercial Services Provides research patenting and licensing services | Commercial Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Commercial Services |
- Stock Market
- Insiders
- Christopher Dinsmore
Choose MarketScreener 
